Page last updated: 2024-09-02
ta 0910 and montirelin
ta 0910 has been researched along with montirelin in 2 studies
Compound Research Comparison
Studies (ta 0910) | Trials (ta 0910) | Recent Studies (post-2010) (ta 0910) | Studies (montirelin) | Trials (montirelin) | Recent Studies (post-2010) (montirelin) |
---|---|---|---|---|---|
64 | 2 | 14 | 61 | 0 | 0 |
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Arrigoni, J; Dement, WC; Kanbayashi, T; Mignot, E; Nishino, S; Shelton, J | 1 |
Deguchi, Y; Hirano, K; Kimura, R; Urayama, A; Yamada, S | 1 |
Other Studies
2 other study(ies) available for ta 0910 and montirelin
Article | Year |
---|---|
Effects of thyrotropin-releasing hormone and its analogs on daytime sleepiness and cataplexy in canine narcolepsy.
Topics: Animals; Cataplexy; Disease Models, Animal; Dogs; Nootropic Agents; Protein Binding; Sleep Stages; Sleep, REM; Thyrotropin-Releasing Hormone; Thyroxine; Triiodothyronine | 1997 |
Brain receptor binding characteristics and pharmacokinetic-pharmacodynamic analysis of thyrotropin-releasing hormone analogues.
Topics: Animals; Binding Sites; Brain; Dose-Response Relationship, Drug; Injections, Intravenous; Male; Rats; Rats, Sprague-Dawley; Receptors, Thyrotropin-Releasing Hormone; Thyrotropin-Releasing Hormone | 2001 |